Disruption of RBMS3 suppresses PD-L1 and enhances antitumor immune activities and therapeutic effects of auranofin against triple-negative breast cancer
Yuting Zhou, Zhongping Liang, Yingjie Xia, Shuai Li, Jiali Liang, Zhixiang Hu, Chengbin Tang, Qing Zhao, Qing Gong, Yongchang Ouyang
Topics & Concepts
AuranofinTriple-negative breast cancerCancer researchPD-L1Immune systemCancerRegulatorDownregulation and upregulationBiologyImmunotherapyCancer cellBreast cancerChemistryImmunologyMedicineInternal medicineBiochemistryGeneRheumatoid arthritisRNA modifications and cancerImmune cells in cancerCancer Immunotherapy and Biomarkers